In the following video, Motley Fool health care analyst Brenton Flynn discusses Bausch & Lomb and the scuttlebutt surrounding a potential acquirer. He talks about Abbott Labs (NYSE: ABT ) , Johnson & Johnson (NYSE: JNJ ) , Sanofi (NYSE: SNY ) , Pfizer (NYSE: PFE ) , and Merck (NYSE: MRK ) , and just how realistic this purchase would be for each. He also gives his bet on which company, in the end, may be the buyer.
Instead of speculating on buyouts, get the inside scoop on what Motley Fool Superinvestor David Gardner will be buying this year. He's crushed the market in his Stock Advisor and Rule Breakers portfolios for years, and now I invite you to a personal tour of his flagship stock picking service: Supernova. Just click here now for instant access.